Stay updated on Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.

Latest updates to the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows revision v3.6.6, replacing the previous v3.6.5, indicating a new page revision. This change involves only revision metadata and does not alter study details or visible content.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now includes a funding attribution for the study, identifying the U.S. NIH Grant/Contract as the funding source.SummaryDifference0.0%

- Check34 days agoChange DetectedVersion 3.6.5 was added and version 3.6.4 removed in the revision history, indicating a backend software upgrade. No user-visible changes to the study details are evident.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows a newer revision number (v3.6.4) replacing the previous v3.6.3, indicating a version update of the page. This likely reflects a minor template or UI/content refresh without altering the study details.SummaryDifference0.0%

- Check77 days agoChange DetectedVersion label updated from v3.6.0 to v3.6.3, indicating a new patch has been applied to the system and the previous version was replaced. This does not appear to alter visible content or user-facing features.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page now states that recruitment has ended and adds guidance sections for readers, while updating the Intervention/Treatment heading formatting and noting a Revision: v3.6.0.SummaryDifference0.1%

Stay in the know with updates to Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.